The Role of Cost-Effectiveness Analysis in the Era of Pharmacogenomics Christopher R. FlowersDavid Veenstra Leading Article 22 September 2012 Pages: 481 - 493
Pharmacogenomics and the Evolution of Healthcare Mohan V. BalaGary A. Zarkin Commentary 22 September 2012 Pages: 495 - 498
Growth Hormone Therapy and Quality of Life in Adults and Children Deborah J. RadcliffeJoseph S. PliskinLeona Cuttler Review Article 22 September 2012 Pages: 499 - 523
An Economic Evaluation of Fluvastatin used for the Prevention of Cardiac Events Following Successful First Percutaneous Coronary Intervention in the UK Paul A. ScuffhamStephen Chaplin Original Research Article 22 September 2012 Pages: 525 - 535
Psychometric and Utility-Based Measures of Health Status of Asthmatic Patients with Different Disease Control Level Ágota SzendeKlas SvenssonGyula Y. Berta Original Research Article 22 September 2012 Pages: 537 - 547
Outcome Measures for Pharmacoeconomics Education Vittorio MaioJennifer H. Lofland Correspondence 22 September 2012 Pages: 549 - 550